Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
---|
01/23/2007 | US7166586 Sulfonamide lactam inhibitors of FXa and method |
01/23/2007 | CA2338311C Prodrugs of the pyridyl methyl sulfinyl benzimidazoles |
01/23/2007 | CA2269946C Naphthyridine derivatives |
01/23/2007 | CA2239968C Pyrimidine derivatives and guanine derivatives, and their use in treating tumour cells |
01/23/2007 | CA2191747C (a)-annelated pyrrole derivatives and pharmaceutical use thereof |
01/18/2007 | WO2007007919A2 Heterocyclic janus kinase 3 inhibitors |
01/18/2007 | WO2007007846A1 Process for producing benzylamine derivative |
01/18/2007 | WO2007006716A1 Cysteine protease inhibitors |
01/18/2007 | WO2007006688A1 Indol-3-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists |
01/18/2007 | WO2007006566A1 Pyridazine compounds as glycogen synthase kinase 3 inhibitors |
01/18/2007 | WO2007006547A1 Amide derivatives as kinase inhibitors |
01/18/2007 | WO2007006546A1 Amide derivatives as kinase inhibitors |
01/18/2007 | WO2007006543A1 Camptothecin analogues, process for their preparation, use and formulations containing them |
01/18/2007 | WO2007006533A2 Indolylmaleimide derivatives |
01/18/2007 | WO2007006211A1 Dipeptidyl peptidase iv (ddp iv) inhibitors, preparation methods and uses thereof |
01/18/2007 | WO2006128120A3 Novel lapachone compounds and methods of use thereof |
01/18/2007 | WO2006126081A3 Pyridino [2 , 3-b] pyrazinones as pde-5 inhibitors |
01/18/2007 | WO2006113140A3 Novel compounds useful for bradykinin b1 receptor antagonism |
01/18/2007 | WO2006036926A3 Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
01/18/2007 | WO2006017443A3 Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds |
01/18/2007 | US20070015801 Bactericides; (5R)-(-)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinecarboxamide |
01/18/2007 | US20070015784 Subsitituted 1,4,8- triazaspiro [4,5]decan-2-one compounds |
01/18/2007 | US20070015783 Substituted 1,4,8-triazaspiro[4,5]decan-2-one compounds |
01/18/2007 | US20070015781 Certain substituted spirocyclic lactams and use thereof as pharmaceuticals |
01/18/2007 | US20070015775 Heterocyclic compounds |
01/18/2007 | US20070015771 Lonidamine analogs |
01/18/2007 | US20070015751 Nitro and amino substituted heterocycles as topoisomerase I targeting agents |
01/18/2007 | US20070015747 Respiratory syncytial virus replication inhibitors |
01/18/2007 | US20070015664 2,4,6-Phenyl substituted cyclic ketoenols |
01/18/2007 | US20070014737 Administering quinine, chlorzoxazone, cyclobenzaprine, carisoprodol via vaporization |
01/18/2007 | CA2615726A1 Indol-3-yl-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists |
01/18/2007 | CA2615291A1 Heterocyclic janus kinase 3 inhibitors |
01/18/2007 | CA2614385A1 Pyridazine compounds as glycogen synthase kinase 3 inhibitors |
01/18/2007 | CA2611607A1 Indolylmaleimide derivatives |
01/18/2007 | CA2610817A1 Cysteine protease inhibitors |
01/17/2007 | EP1743896A2 A process for the purification of imiquimod |
01/17/2007 | EP1742948A2 Bicyclic heterocycles as kinase inhibitors |
01/17/2007 | EP1742947A1 6-substituted pyridoindolone derivatives production and therapeutic use thereof |
01/17/2007 | EP1742946A1 Dialkoxy-imidazopyridines derivatives |
01/17/2007 | EP1742945A1 Substituted phenylamino-pyrimidines |
01/17/2007 | EP1742944A1 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
01/17/2007 | EP1742939A2 Novel alkyne compounds exhibiting an mch antagonistic effect and drugs containing said compounds |
01/17/2007 | EP1742936A2 Polycyclic pyridines as potassium ion channel modulators |
01/17/2007 | EP1742934A2 Piperidine derivatives as modulators of chemokine receptor ccr5 |
01/17/2007 | EP1742927A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof |
01/17/2007 | EP1742925A1 Substituted 5, 6, 7, 8-tetrahydro-pyrido[4, 3-d]pyrimidine-2-yl compounds and 5, 6, 7, 8-tetrahydro-quinazoline-2-yl compounds |
01/17/2007 | EP1742919A2 Tetrahydropyranyl cyclopentyl 1-substituted and 1,1-disubstituted tetrahydroisoquinoline modulators of chemokine receptor activity |
01/17/2007 | EP1742915A2 Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulators of chemokine receptor activity |
01/17/2007 | EP1742907A2 Certain chemical entities, compositions, and methods |
01/17/2007 | EP1742642A2 Phosphonate analogs of hiv integrase inhibitor compounds |
01/17/2007 | EP1742628A1 Alternative forms of the phosphodiesterase-4 inhibitor n-cyclopropyl-1-{3-¬(1-oxidopryidin-3-yl)ethynyl|phenyl}-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxyamide |
01/17/2007 | EP1537110B1 Triazospiro compounds having nociceptin receptor affinity |
01/17/2007 | EP1341793B1 Crf receptor antagonists and methods relating thereto |
01/17/2007 | EP1268444B1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents |
01/17/2007 | EP1070068B2 Granulatimide derivatives for use in cancer treatment |
01/17/2007 | CN1898247A Polycyclic agents for the treatment of respiratory syncytial virus infections |
01/17/2007 | CN1898244A Triazole derivatives as vasopressin antagonists |
01/17/2007 | CN1898239A Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
01/17/2007 | CN1898238A Oxazolidinone-quinolone hybrid antibiotics |
01/17/2007 | CN1898227A Ornithine derivatives as prostaglandin e2 agonists or antagonists |
01/17/2007 | CN1897948A Alkoxy substituted imidazoquinolines |
01/17/2007 | CN1897941A Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
01/17/2007 | CN1896076A Tricyclic-type compound, and medicine having it as effective component |
01/17/2007 | CN1895673A The use of substituted tetracyclic imidazole derivatives as anti-histaminics |
01/17/2007 | CN1295228C Nitryl methylene derivatives and uses thereof |
01/16/2007 | US7164023 Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate |
01/16/2007 | US7164021 Intensify therapy of analgesics; immunology diseases; antiinflammatory agents; drug abuse; diarrhea; cardiovascular disorders; antisecretory agents; respiratory system disorders |
01/16/2007 | US7163948 interact with regions of DNA that can form quadruplexes and act as tumor suppression genes with high affinity; can reduce expression of highly proliferate genes and are utilized for treating cancers |
01/16/2007 | US7163947 1-Amino 1H-imidazoquinolines |
01/16/2007 | US7163941 Pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents |
01/16/2007 | US7163940 Pyrazolopyridinyl pyrimidine therapeutic compounds |
01/16/2007 | CA2254755C Hexahydro-pyrido(4,3-b)indole derivatives as antipsychotic drugs |
01/11/2007 | WO2007005887A2 Androgen receptor modulator compounds, compositions and uses thereof |
01/11/2007 | WO2007004958A1 Pyridopyrimidine derivatives as pde4 inhibitors for the treatment of inflammatory and' immune diseases |
01/11/2007 | WO2007003965A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists |
01/11/2007 | WO2007003964A1 G-protein coupled receptor agonists |
01/11/2007 | WO2007003961A2 Gpcr agonists |
01/11/2007 | WO2007003765A1 Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the same |
01/11/2007 | WO2007003611A1 Pyrroloquinoline derivatives and their use as protein kinase inhibitors |
01/11/2007 | WO2007003536A1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect |
01/11/2007 | WO2007003522A1 Method for obtaining a pharmaceutically active compound, synthesis intermediates thereof and methods for obtaining them |
01/11/2007 | WO2007003386A1 Imidazopyridine derivatives as acid pump antagonists |
01/11/2007 | WO2006123061A3 Fluorene derivatives, composition containing said derivatives and the use thereof |
01/11/2007 | WO2006026754A3 Bicyclic heteroaryl pde4b inhibitors |
01/11/2007 | WO2006009734A8 Gonadotropin releasing hormone receptor antagonists |
01/11/2007 | WO2005076815A3 PERYLENE n-TYPE SEMICONDUCTORS AND RELATED DEVICES |
01/11/2007 | US20070010675 Process for the purification of imiquimod |
01/11/2007 | US20070010674 Method of synthesizing camptothecin-relating compounds |
01/11/2007 | US20070010672 Inks, colorants, pigmented plastics for coatings, non-impact-printing material, color filters, cosmetics, polymeric ink particles, toners, fluorescent tracers; high in the efficiency of electrical energy utilisation and high in luminance |
01/11/2007 | US20070010568 highly potent; side effect reduction; for the treatment of diseases of the respiratory, urinary and gastrointestinal systems; 3-(2-Methoxy-5-methylphenyl)-3-phenylpropionic acid-(3-benzyl-3-azabicyclo[3.1.0]hex-6-yl-carbamoyl)methyl ester; condensation; deprotection |
01/11/2007 | US20070010561 Prenylation inhibitors and methods of their synthesis and use |
01/11/2007 | US20070010549 Imidazo(4,5-b)pyridine-derivatives as inducible no-synthase inhibitors |
01/11/2007 | US20070010548 Compounds having inhibitive activity of phosphatidylinositol 3-kinase and methods of use thereof |
01/11/2007 | US20070010544 e.g. 4,7,7-trimethyl-7, 12,12a,6a-tetrahydrochromano[4,3-b]quinoline; increasing cellular ATP binding cassette transporter ABCA1 production ; reduces cholesterol deposition in coronary arteries; coronary artery diseases, dyslipidiemias and metabolic syndrome |
01/11/2007 | US20070010530 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
01/11/2007 | US20070010521 Condensed polycyclic compounds |
01/11/2007 | US20070010512 Heterocyclic substituted 1,4-dihydro-4-oxo-1,8-naphthpyridine analogs |
01/11/2007 | US20070010489 Saquinavir-like, a Lopinavir-like, a Ritonavir-like, a Indinavir-lik, a atazanavir-like, Nelfinavir-like.a Tipranavir-like, a Amprenavir-like, a KNI-like. a cyclic carbonyl-like phosphonate HIV protease inhibitors; drug designing |
01/11/2007 | CA2613236A1 G-protein coupled receptor agonists |
01/11/2007 | CA2613211A1 Pyrroloquinoline derivatives and their use as protein kinase inhibitors |